Overview

Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
0
Participant gender:
All
Summary
The primary purpose of this study is to explore the safety and tolerability of AZD4547 in Japanese patients with advanced solid malignancies.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AstraZeneca
Criteria
Inclusion Criteria:

- Japanese patients with advanced solid malignancies Over 25 years old Relatively good
overall health other than cancer

Exclusion Criteria:

- Poor bone marrow function (not producing enough blood cells). Poor liver or kidney
function. Refractory nausea and vomiting, chronic gastrointestinal diseases, inability to
swallow the IP or previous significant bowel resection.